Clinical Trials Logo

Corneal Opacity clinical trials

View clinical trials related to Corneal Opacity.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06000150 Completed - Corneal Opacity Clinical Trials

Characteristics of Trachomatous Corneal Opacity in Fayoum University Hospital

Trachoma
Start date: February 1, 2022
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to assess the characteristics of trachomatous corneal opacity in patients with signs of trachoma using Anterior segment Optic coherence tomography and Pentacam

NCT ID: NCT05014269 Completed - Senile Cataract Clinical Trials

Phacoemulsification in Patients With Corneal Opacities

Start date: January 1, 2015
Phase:
Study type: Observational

In this retrospective case series, the feasibility of performing phacoemulsification using slit illumination in eyes with corneal opacity was assessed.

NCT ID: NCT04752969 Completed - Corneal Opacity Clinical Trials

The Effect of Thyroid Hormon Levels on the Corneal Measures

Start date: June 15, 2020
Phase:
Study type: Observational

In this cross-sectional comparative study, it is aimed to investigate the topographic measurements,aberrometrics and densitometrics values of corneas in hypothyroid and hyperthyroid patients compared to healthy individuals. A number of 20 hypothyroid patients (group I), 20 hyperthyroid patients (group II), and 20 age-matched healthy controls (group III) have been recruited. The Pentacam high resolution imaging system is used to determine corneal topographic measurements,aberrometry and densitometry.

NCT ID: NCT03123614 Completed - Clinical trials for Intraocular Pressure

Loteprednol vs. Prednisolone and Fluorometholone

Start date: September 19, 2014
Phase: Phase 4
Study type: Interventional

Corneal haze, in which the cornea becomes cloudy, is a well-known and a potentially vision-threatening postoperative complication of photorefractive keratectomy (PRK). Topical ophthalmic corticosteroids are routinely prescribed by most surgeons postoperatively to help prevent this complication. Goals of topical steroids use after PRK include effective modulation of the healing response to prevent corneal haze while at the same time minimizing side effects, such as intraocular pressure elevation or cataract formation. Loteprednol etabonate is a corticosteroid that exerts its therapeutic effects and is then quickly changed into inactive metabolites. This relatively fast metabolism of loteprednol gives it a lower side effect profile than other steroids, including a smaller effect on intraocular pressure. In the ophthalmic literature, there is currently no consensus on a standard regimen or which type of corticosteroid should be used after PRK. Investigators are conducting a prospective, randomized trial to compare the incidence of intraocular pressure rise and visually significant postoperative corneal haze after PRK with the use of loteprednol 0.5% gel compared to the use of earlier generation steroids, prednisolone acetate 1% suspension and fluorometholone 0.1% suspension.

NCT ID: NCT02301598 Completed - Keratoconus Clinical Trials

Femtosecond Laser-assisted Anterior Lamellar Keratoplasty

Start date: January 2012
Phase: N/A
Study type: Interventional

The purpose of the study is evaluating safety and clinical efficiency of full femtosecond laser-assisted anterior lamellar keratoplasty (FS-ALK) for curing patients with keratoconus and corneal opacities

NCT ID: NCT02173847 Completed - Keratoconus Clinical Trials

Laser Assisted Procedures in Penetrating Keratoplasty

Start date: January 2011
Phase: N/A
Study type: Interventional

Laser- assisted procedures in penetrating keratoplasty (PK) are proposed to improve the surgical outcomes: minimally invasive procedures, improved biomechanical stability of the transplanted flap, reduction of rejection risks, reduction of inflammation, reduction of infections risk, faster healing process. In order to achieve these goals, two different lasers were used during PK surgery: - a femtosecond laser to cut an anvil shaped profile - a diode laser to weld the surgical wound

NCT ID: NCT02117323 Completed - Corneal Opacities Clinical Trials

Corneal Opacities in Children

OCT
Start date: September 2011
Phase:
Study type: Observational

A prospective observational study on corneal opacities in infants and children (1 month to 18 years old) will be conducted at CHLA. Most of these cases will be due to congenital corneal opacity (e.g. Peter's anomaly, mucopolysacharidoses) or scarring due to infectious keratitis. Sixty (60) subjects will be recruited. The children will be examined under anesthesia with a portable slit-lamp and OCT. An iVue OCT system (Optovue) attached to an operating microscope-style mount at CHLA will be used for the intraoperative scans. Both cross-sectional and 3-D OCT scans will be performed to assess opacity depth, pachymetry map, endothelial defects, and any abnormal adhesion between the cornea, iris and lens. The anterior chamber angle will also be imaged with cross-sectional OCT to assess angle depth, trabecular meshwork, Schwalbe's line, and possible peripheral iridocorneal adhesion or posterior embryotoxon. OCT of the crystalline lens will be obtained to assess the presence of cataract. Slit-lamp photography will be obtained, and gonioscopy will be performed if indicated. Corneal diameter will be measured with a caliper, and intraocular pressure will be measured with a tonopen (Reichert).

NCT ID: NCT00439114 Completed - Corneal Opacity Clinical Trials

Comparison of Ultrasonic Pachymetry With Orbscan in Corneal Haze

Start date: July 2005
Phase: N/A
Study type: Observational

This study is planned to compare the results of ultrasonic and Orbscan pachymetry in corneal haze not related to surgery. Corneal haze is graded with slit-lamp by a single examiner. Ultrasonic and Orbscan II pachymetry measurements are obtained. Paired t and Kruskal-Wallis tests are used to evaluate the difference between ultrasonic and Orbscan pachymetry measurements. Correlation of the two methods and haze grade is determined with Kendall’s tau-b correlation analysis.